ChatBot Beta

Governance Bristol-Myers Squibb Company

BMY

US1101221083

Pharmaceuticals

Market Closed - Nyse Other stock markets 04:00:02 2025-02-11 pm EST			After market 04:22:01 pm
55.94 ^USD	+0.74%		56.14	+0.36%

Feb. 10	Daiwa Securities Adjusts Bristol-Myers Squibb Price Target to $60 From $65, Maintains Outperform Rating	MT
Feb. 10	Bristol Myers Squibb Sees Positive Results for Breyanzi in Lymphoma Trials	DJ

Executive Committee: Bristol-Myers Squibb Company

Manager

Positions heldSince

Christopher Boerner

54 year

Chief Executive Officer

2023-10-31

Sandra Leung

64 year

General Counsel

2006-12-31

Catalina Vargas

Human Resources Officer

Phil Holzer

49 year

Comptroller/Controller/Auditor

2014-12-31

Robert Plenge

54 year

Chief Tech/Sci/R&D Officer

2019-10-31

Estelle Vester-Blokland

Chief Tech/Sci/R&D Officer

Greg Meyers

Chief Tech/Sci/R&D Officer

Kimberly McCutcheon Jablonski

Compliance Officer

2023-09-30

Samit Hirawat

56 year

Chief Tech/Sci/R&D Officer

2018-12-31

David Elkins

57 year

Director of Finance/CFO

2019-11-19

Composition of the Board of Directors: Bristol-Myers Squibb Company

Director

CommitteesSince

Christopher Boerner

54 year

Chairman

2024-03-31

Theodore Samuels

70 year

Audit Committee	2017-02-20
Governance Committee Chair
Compensation Committee	2021-12-31
HR Committee	2021-12-31
Finance Committee	2023-07-16
Governance Committee	2023-07-16
Nominating Committee	2023-07-16

Paula Price

64 year

Compensation Committee	2014-05-08
HR Committee	2014-05-08
Audit Committee Chair	2021-12-31
Audit Committee
Governance Committee

Phyllis Yale

67 year

Governance Committee Chair	2016-07-10
Nominating Committee Chair	2016-07-10
Audit Committee
Governance Committee	2019-12-04

Derica Rice

60 year

Audit Committee Chair
Compensation Committee
Audit Committee	2021-07-21
Finance Committee	2020-08-30

Michael McMullen

64 year

Compensation Committee	2023-07-23
Audit Committee	2024-06-30

Julia Haller

70 year

Governance Committee	2022-08-10
Nominating Committee	2022-08-10

Manuel Hidalgo Medina

57 year

Governance Committee	2024-07-16
Nominating Committee	2024-07-16

Karen Vousden

67 year

Compensation Committee

2017-12-31

Deepak Bhatt

57 year

Compensation Committee

2022-06-13

Peter Arduini

60 year

Compensation Committee

2016-03-31

Latest Appointments: Bristol-Myers Squibb Company

Verastem Oncology Appoints Matthew E. Ros as Chief Operating Officer	Jan. 15	CI
Annexon, Inc. Appoints William ?BJ? Jones to Its Board of Directors	Jan. 10	CI
Lexicon Pharmaceuticals, Inc. Appoints Scott M. Coiante as Senior Vice President	Jan. 02	CI
CytoDyn Appoints Max Lataillade as Senior Vice President and Head of Clinical Development	24-10-08	CI
Inozyme Pharma, Inc. Announces Appointment of Erik Harris to its Board of Directors	24-10-07	CI
Acadia Pharmaceuticals Appoints Catherine Adams as CEO	24-09-23	MT
Lincoln Financial Reports Passing of Board Member Michael F. Mee	24-09-18	CI

More news

Former Officers and Directors: Bristol-Myers Squibb Company

Insider

Positions held

SinceUntil

Vicki Sato

Director/Board Member	2006-07-10	2021-05-03
Independent Dir/Board Member	2006-07-10	2021-05-03

Michael Grobstein

Director/Board Member	2007-03-05	2020-05-04
Independent Dir/Board Member	2007-03-05	2020-05-04

John E. Elicker

Investor Relations Contact	1999-12-31	2020-03-30
Public Communications Contact	1999-12-31	2020-01-05

Joseph C. Caldarella

Comptroller/Controller/Auditor

2009-12-31

2018-02-14

Laurie Glimcher

Director/Board Member	1996-12-31	2017-07-20
Independent Dir/Board Member	1996-12-31	2017-07-20

Lamberto Andreotti

Director/Board Member	2008-12-31	2014-12-31
Chief Executive Officer	2010-05-03	2015-05-04
Chairman	2014-12-31	2017-05-01
Chief Operating Officer	2008-04-30	2010-04-30
Corporate Officer/Principal	1997-12-31	2008-04-30

James Cornelius

Chief Executive Officer	2006-09-11	2010-05-03
Chairman	2006-08-31	2015-05-04
Independent Dir/Board Member	2004-12-31	2015-05-04
President	2006-08-31	2013-02-13

John E. Celentano

Human Resources Officer	2011-05-12	2012-10-07
Public Communications Contact	2011-05-12	2012-10-07
Corporate Officer/Principal	1999-12-31	2013-06-30

Charles Sigal

Director/Board Member	2011-03-02	2013-05-31
Chief Tech/Sci/R&D Officer	2004-09-30	2013-05-31

Robert Williams

Director/Board Member	2006-09-10	2013-05-30
Independent Dir/Board Member	2011-05-11	2013-05-30

Louis J. Freeh

Director/Board Member	2004-12-31	2013-03-06
Independent Dir/Board Member	2011-05-10	2013-03-06

Anthony Hooper

Chief Operating Officer	2011-05-12	2011-10-19
Corporate Officer/Principal	1995-12-31	2011-05-12

Leif Valdemar Johansson

Director/Board Member	1997-12-31	2011-09-19
Independent Dir/Board Member	2011-05-10	2011-09-19

Carlo de Notaristefani

Corporate Officer/Principal

2003-12-31

2011-06-30

Blaine Davis

Corporate Officer/Principal

2004-12-31

2008-04-30

Stephen E. Bear

Human Resources Officer

2000-12-31

2008-03-30

Richard K. Willard

General Counsel

2004-12-31

2007-05-10

Andrew Bonfield

Director of Finance/CFO

2001-12-31

2006-12-31

David J. Helfgott

Chief Operating Officer	2006-11-14	-
President	2006-11-14	-

Louis Sullivan

Director/Board Member

2006-05-01

Louis Gerstner

Director/Board Member	-	2006-05-01
Independent Dir/Board Member	-	2006-05-01

Donald Hayden

Corporate Officer/Principal

1980-12-31

2005-12-31

John L. McGoldrick

General Counsel

1994-12-31

2005-09-30

Robert T. Zito

Public Communications Contact

2004-05-31

Edward M. Dwyer

Treasurer

2003-12-31

Dean Mitchell

Corporate Officer/Principal

2000-12-31

2003-12-31

Juan F. Sanchez

Corporate Officer/Principal

2003-10-31

Carol Marino

Corporate Officer/Principal

1995-08-31

2002-12-31

Richard L. Wolgemuth

General Counsel

2002-12-31

Fabio M. Benedetti

Chief Tech/Sci/R&D Officer

1999-06-30

2002-04-30

Steven E. Benner

Chief Tech/Sci/R&D Officer

1994-12-31

2001-12-31

Stacey M. Lituchy

Corporate Officer/Principal

2001-12-30

Gary Dickinson

Human Resources Officer

1996-12-31

2001-03-31

David L. Zabor

Corporate Officer/Principal

2000-12-31

Stacey Latuche

Portfolio Manager-Equities

2000-12-30

Robert L. Simon

General Counsel

1986-12-31

2000-06-30

Jaisim Shah

Sales & Marketing

1997-06-30

2000-06-30

Ronald Pepin

Chief Tech/Sci/R&D Officer

1990-02-28

2000-06-30

Myrtle Potter

Corporate Officer/Principal

1995-12-31

2000-04-30

Andrew Bodnar

Chief Tech/Sci/R&D Officer

1999-12-31

Kin Yip Leung

Corporate Officer/Principal

1989-12-31

1999-01-31

Nicole Onetto

Chief Tech/Sci/R&D Officer

1991-06-30

1997-04-30

Joachim von Roy

Corporate Officer/Principal

1996-12-31

Kenneth Anderson

Sales & Marketing

1979-12-31

1996-12-31

William Scott

Corporate Officer/Principal

1989-12-31

1996-12-30

N. Coles

Corporate Officer/Principal

1995-12-31

Robert B. Ross

Corporate Officer/Principal

1990-12-31

1994-12-30

Patrick J. Fortune

Corporate Officer/Principal

1991-11-30

1994-07-31

Mark J. Carvlin

Sales & Marketing

1988-12-31

1993-12-30

Lawrence Hamilton

Chief Administrative Officer	1984-12-31	1993-07-31
Human Resources Officer	1984-12-31	1993-07-31

Barry Wilson

Corporate Officer/Principal

1979-12-31

1992-12-31

Henry Y. Pan

Corporate Officer/Principal

1984-12-31

1991-12-31

Steven Ratoff

Director of Finance/CFO	1974-12-31	1990-12-31
Corporate Officer/Principal	1974-12-31	-

George Zavoico

Corporate Officer/Principal

1987-12-31

Robert A. Fildes

Chief Operating Officer

1974-12-31

1979-12-31

Guo Wei Wang

Corporate Officer/Principal

Mark Gleason

Corporate Officer/Principal

Robert Laurenzo

Corporate Officer/Principal

H. Perry Fell

Corporate Officer/Principal

Alexander MacPherson

Corporate Officer/Principal

Jonas Wang

Corporate Officer/Principal

Steven Girgenti

Corporate Officer/Principal

Jerry Frantz

Sales & Marketing

Salvatore Forenz

Director/Board Member

Sales & Marketing

Sales & Marketing

Treasurer

Chief Tech/Sci/R&D Officer	-	-
President	-	-

Arthur C. Louie

Corporate Officer/Principal

Jay Moorin

Corporate Officer/Principal

Anthony Plohoros

Public Communications Contact

Ronald Thiboutot

Corporate Officer/Principal

Paul Karr

Comptroller/Controller/Auditor

Andrew Forman

Corporate Officer/Principal

John L. Skule

Public Communications Contact

Greg W. Cashman

Director of Finance/CFO

1995-12-30

Dan R. Burns

Corporate Officer/Principal

Age distribution of managers

Parity Men Women

Male	21
Female	8

Of which Executive Committee

Male	6
Female	4

Of which Directors

Male	9
Female	2

Revisions

1 year Revenue revision

4 months Revenue revision

1 months Revenue revision

1 year EPS revision

4 months EPS revision

ESG MSCI

ESG

Environment

Social

Governance

Controversy

ESG: Ethical controversies

ESG: Human rights controversies

ESG: Tax subsidies controversies

Sharia compliant

Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques. The United States account for 70.1% of net sales.

Employees

34,100

Sector

Pharmaceuticals

Calendar

2025-04-24 - Q1 2025 Earnings Release

More about the company